Cadiflu: Cadila Pharma Introduces Vaccine For Seasonal Flu

Cadiflu: Cadila Pharma Introduces Vaccine For Seasonal Flu

The drug firm has been approved by the DCGI (Drugs Controller General of India) for use in adults and children.

PTIUpdated: Monday, March 04, 2024, 04:29 PM IST
article-image
Cadiflu | Cadila Pharma

Ahmedabad-based Cadila Pharmaceuticals on Monday said it has launched a vaccine to prevent influenza, a recurrent and widespread viral infection. The drug firm has introduced quadrivalent Cadiflu Tetra vaccine which has been approved by the DCGI (Drugs Controller General of India) for use in adults and children. The new vaccine targets four strains of the influenza virus subtype -A and B, responsible for seasonal epidemics, the drug firm said in a statement.

Developed using proprietary technology employing nano-sized particles, the vaccine mimics the external structure of the virus without containing intact genetic material, it added.

"This breakthrough in vaccine development also holds promise for enhancing the protection of pregnant women against influenza, contributing to the overall well-being of both mother and child," Cadila Pharmaceuticals CMD Rajiv I Modi said.

Influenza, commonly known as seasonal flu, is a highly contagious acute respiratory illness caused by viruses and is said to affect many throughout the globe.

RECENT STORIES

Can You Finally Own A Home In Mumbai? BMC Opens Applications For 426 Affordable Flats In Prime...

Can You Finally Own A Home In Mumbai? BMC Opens Applications For 426 Affordable Flats In Prime...

Gold Surges Over 50% In 2025, Breaches $4,000 As Asia-Led Bull Run Rivals Historic Rallies

Gold Surges Over 50% In 2025, Breaches $4,000 As Asia-Led Bull Run Rivals Historic Rallies

Sahara India Investors Finally Get Relief, Government Launches Online Refund Portal—Know How To...

Sahara India Investors Finally Get Relief, Government Launches Online Refund Portal—Know How To...

Food Delivery & Quick Commerce Firm Eternal Posts ₹65 Crore Consolidated Profit In Q2

Food Delivery & Quick Commerce Firm Eternal Posts ₹65 Crore Consolidated Profit In Q2

M3M India To Invest ₹2,100 Crore For Jacob & Co Branded Ultra-Luxury Residences In Noida, Eyes...

M3M India To Invest ₹2,100 Crore For Jacob & Co Branded Ultra-Luxury Residences In Noida, Eyes...